← Back to Search

Somatosensory Feedback for Speech Perception

N/A
Recruiting
Led By David Ostry
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
no known physical or neurological abnormalities
Be between 18 and 65 years old
Must not have
currently taking antianxiety drugs
surgical clips or values on the heart
Timeline
Screening 3 weeks
Treatment Varies
Follow Up performance as measured at the end of learning (30 minute session)
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if changes to the brain's perception of speech sounds occur when the same sounds are paired with physical sensations.

Who is the study for?
This trial is for right-handed adults with no known physical or neurological abnormalities. It's not suitable for those on antidepressants, antipsychotics, or anti-anxiety drugs; individuals with a pacemaker, metal implants, or fragments; anyone who is claustrophobic, pregnant, or has a personal/family history of epilepsy.
What is being tested?
The study tests if repeated pairing of touch (somatosensory inputs) and speech sounds can change how we perceive these sounds. Participants will experience facial skin stretching as part of the process to see if it affects speech perception.
What are the potential side effects?
Since this trial involves non-invasive procedures like adaptation and facial skin stretch rather than drug interventions, significant side effects are not expected. However, discomfort from the skin stretching could occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I do not have any known physical or neurological abnormalities.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently on medication for anxiety.
Select...
I have surgical clips or valves in my heart.
Select...
I am currently on antidepressants.
Select...
I am currently on antipsychotic medication.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~performance as measured at the end of learning (30 minute session)
This trial's timeline: 3 weeks for screening, Varies for treatment, and performance as measured at the end of learning (30 minute session) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Speech Motor Learning
Speech Perception

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Group I: Speech Repetition ControlExperimental Treatment1 Intervention
Speech Repetition Control
Group II: Adaptation to Altered Auditory Feedback + Forward Skin StretchExperimental Treatment2 Interventions
Adaptation to Altered Auditory Feedback + Forward Skin Stretch
Group III: Adaptation to Altered Auditory Feedback + Backward Skin StretchExperimental Treatment2 Interventions
Adaptation to Altered Auditory Feedback + Backward Skin Stretch
Group IV: Adaptation to Altered Auditory FeedbackExperimental Treatment1 Intervention
Adaptation to Altered Auditory Feedback

Find a Location

Who is running the clinical trial?

McGill UniversityOTHER
414 Previous Clinical Trials
1,015,281 Total Patients Enrolled
2 Trials studying Speech
176 Patients Enrolled for Speech
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
361 Previous Clinical Trials
181,898 Total Patients Enrolled
15 Trials studying Speech
1,891 Patients Enrolled for Speech
Yale UniversityLead Sponsor
1,930 Previous Clinical Trials
3,033,314 Total Patients Enrolled
6 Trials studying Speech
940 Patients Enrolled for Speech
David OstryPrincipal InvestigatorHaskins Laboratories
6 Previous Clinical Trials
940 Total Patients Enrolled
6 Trials studying Speech
940 Patients Enrolled for Speech

Media Library

Adaptation Clinical Trial Eligibility Overview. Trial Name: NCT04818021 — N/A
Speech Research Study Groups: Adaptation to Altered Auditory Feedback, Adaptation to Altered Auditory Feedback + Forward Skin Stretch, Adaptation to Altered Auditory Feedback + Backward Skin Stretch, Speech Repetition Control
Speech Clinical Trial 2023: Adaptation Highlights & Side Effects. Trial Name: NCT04818021 — N/A
Adaptation 2023 Treatment Timeline for Medical Study. Trial Name: NCT04818021 — N/A
~16 spots leftby Jul 2025